Orphanse Healthcare is a drug company focusing on development of novel therapeutics in Emergency Care & Rescue Therapy. Our aim is to provide to healthcare professionals & patients with oromucosal treatments addressing significant unmet medical needs. Orphanse Healthcare pipeline is composed by differentiated products with rapid development program. Following EMA's Scientific Advice, our pilot program, ORH-01 enters into clinical phase in Q2-2018 with expected submission in Q1-2020.